Report of the PDG 30th Anniversary Symposium　　　　　　 - The History and Future Perspective of PDG -

13:30～13:35

Opening remarks

Mr. Kazuhiko Mori
(Minister’s Secretariat, Councilor for Pharmaceutical Affairs, MHLW)

13:35～13:55

The history of PDG

Ms. Fumi Yamamoto
(Director, Pharmaceutical Evaluation Division,
Pharmaceutical Safety and Environmental Health Bureau, MHLW)

13:55～14:55

Introduction and expectation for PDG from each pharmacopoeia

EP: Dr. Susanne Keitel
(Director, European Directorate for the Quality of Medicines)

JP: Dr. Takao Yamori (Executive Director, PMDA)
USP: Dr. Jaap Venema (Chief Science Officer & Chair, Council of Experts, USP)

14:55～15:15

WHO & PDG

Dr. Sabine Kopp
(Group Lead, Medicines Quality Assurance, World Health Organization)

15:15～15:35

Break

15:35～16:35

Expectation for PDG from Stakeholders

Dr. Yasuyo Ozaki (The European Federation of Pharmaceutical Industries and
Associations/ The Pharmaceutical Research and Manufacturers of America)
Dr. Mikio Suzuki (The Pharmaceutical Manufacturers’ Association of Tokyo)
Dr. Yoshinori Hayashi (Kansai Pharmaceutical Industries Association)
Ms. Priscilla Zawislak
(President, International Pharmaceutical Excipients Council)

16:35～16:55

Latest activity of PDG

Dr. Haruhiro Okuda (Chair of Expert Committee, Japanese Pharmacopoeia)

16:55～17:00

Closing remarks

Dr. Yoshikazu Hayashi (Senior Executive Director, PMDA)